"we were quite surprised to find there were no significant differences," says study author . .
plemmons and co-authors disclosed no relevant relationships with industry. .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
sign in to get notified via email when new comments are made.
.
OFF DEAL
OFF DEAL
181 Used Today
OFF DEAL
200 Used Today